Kutti J, Wadenvik H, Henestam B, Stenström G
Acta Med Scand. 1986;219(2):195-9. doi: 10.1111/j.0954-6820.1986.tb03298.x.
Seventeen patients with insulin-dependent diabetes mellitus, all below the age of 45 years, were studied. Five of them had retinopathy but no other micro- or macrovascular diabetic complications. None of them had any other concurrent disorder or were on any medication but insulin. The results were compared to those of 17 healthy volunteers of comparable age. There was no difference between the two groups in venous platelet counts, serum production of thromboxane B2 (TXB2), ADP-induced platelet aggregation or bleeding times. As compared to the controls, the diabetics had significantly elevated blood glucose and glycosylated hemoglobin values. The mean plasma values of beta-thromboglobulin, platelet factor 4 and TXB2 were significantly lower in the patients than in the controls. Thus, our results do not lend support to the current concept that platelet reactivity is enhanced in diabetes mellitus.
对17名年龄均在45岁以下的胰岛素依赖型糖尿病患者进行了研究。其中5人患有视网膜病变,但无其他糖尿病微血管或大血管并发症。他们均无其他并发疾病,除胰岛素外未服用任何药物。将结果与17名年龄相仿的健康志愿者的结果进行了比较。两组在静脉血小板计数、血栓素B2(TXB2)的血清生成、ADP诱导的血小板聚集或出血时间方面无差异。与对照组相比,糖尿病患者的血糖和糖化血红蛋白值显著升高。患者的β-血小板球蛋白、血小板因子4和TXB2的平均血浆值明显低于对照组。因此,我们的结果不支持目前关于糖尿病患者血小板反应性增强的观点。